查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447731

器官保存市场评估：按解决方案、技术、器官类型、最终用户和地区划分的机会和预测（2017-2031）

Organ Preservation Market Assessment, By Solution, By Technique, By Organ Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5个工作天内

价格

全球器官保存市场规模将从2023年的2.8186亿美元增长到2031年的4.7176亿美元，在2024年至2031年的预测期内复合年增长率为6.65%。预计规模将会增长。

受全球器官移植数量增加以及延长器官保存期限和维持高器官存活率技术进步等驱动力的影响，器官保存市场预计将呈指数级增长。事实确实如此。 此外，投资者的支持和不断增长的医疗保健支出也正在推动市场成长。 越来越多的器官衰竭导致需要器官移植的病例也进一步增加了器官保存市场的需求。 器官移植手术的增加和器官研究的迅速增加，对器官保存解决方案的需求显着增加。 近年来，监管日益受到重视，多种相关产品的多项监管批准加强了主要参与者的市场地位。 政府对器官移植的支持和各个非营利组织的努力也进一步推动了市场需求。 另一方面，器官移植相关的高成本和併发症是市场成长的主要挑战。 此外，捐赠的器官与正在进行的器官移植之间的差距是市场扩张的另一个障碍。

器官移植数量增加

器官移植数量的不断增加正在推动对器官保存产品的需求。 解剖后的器官往往会很快恶化，因此器官保存液在移植前保护器官方面发挥重要作用。 器官移植增加的原因包括临床进步、可支配收入增加以及对器官捐赠和移植的认识提高。 根据器官取得和移植网发布的数据，2023年，死亡器官捐赠者数量将达到前所未有的高位，达到16,000人，这将是连续13年创下捐赠纪录。 此外，年内器官移植数量急剧增加，为克服器官衰竭而实施了超过 46,000 例挽救生命的手术。 其中，肝臟移植首次突破1万例，肺臟移植首次突破3000例。 此外，肾臟和心臟移植也创下了今年的新纪录，凸显了器官移植的令人瞩目的进展。

器官保存方法的进展

多年来，器官保存方法逐渐进步，以优化器官移植结果。 随后的创新包括复杂的配方，例如柯林斯、欧洲柯林斯和威斯康辛大学 (UW) 的解决方案，可延长保质期并提高器官活力。 目前，进入者正专注于开发具有復兴策略的产品，特别是提供模仿生理条件的动态环境的机械灌注系统。 这些系统为器官修復和长期保存提供了机会，减少了过程失败的可能性。 离体灌注是机械灌注的延伸之一，旨在透过进一步的修復机制和重编程过程进一步增强器官恢復。

本报告调查了全球器官保存市场，提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及影响市场成长的因素分析、案例研究、竞争格局、主要公司的简介等等。

目录

第1章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第4章全球器官保存市场展望

  • 市场规模/预测
  • 按解决方案
    • 威斯康辛大学 (UW)
    • 託管 HTK
    • Perfadex
    • 其他
  • 按技术
    • 静态冷库
    • 低温机械灌注
    • 常温机械灌注
  • 依器官类型
    • 肾臟
    • 肝臟
    • 肺
    • 心
    • 胰臟
    • 其他
  • 按最终用户
    • 器官移植中心
    • 医院
    • 专科诊所
  • 按地区
    • 北美
    • 欧洲
    • 南美洲
    • 亚太地区
    • 中东/非洲
  • 各公司的市占率

第5章全球器官保存市场展望：按地区

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第 6 章市场映射

  • 按解决方案
  • 按技术
  • 依器官类型
  • 按最终用户
  • 按地区

第7章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 抑制生长的因素（问题/抑制因素）

第 9 章监理架构与创新

  • 临床试验
  • 专利情况
  • 监理机关的核准
  • 创新/新兴技术

第10章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（主要公司）

第11章价格分析

第 12 章案例研究

第13章主要公司展望

  • XVIVO Perfusion AB
  • TransMedics, Inc.
  • Preservation Solutions, Inc.
  • Paragonix Technologies, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Waters Medical Systems LLC
  • OrganOx Limited
  • st Century Medicine Inc.
  • Bridge to Life Ltd.
  • Essential Pharmaceuticals LLC

第 14 章策略建议

第15章关于我们公司/免责声明

Product Code: MX11138

Global organ preservation market is projected to witness a CAGR of 6.65% during the forecast period 2024-2031, growing from USD 281.86 million in 2023 to USD 471.76 million in 2031. The organ preservation market is anticipated to thrive exponentially under the influence of driving forces like the growing number of organ transplants being performed worldwide, and technological advancements to enhance the preservation time and maintain the high viability of organs. Additionally, rising investors' traction and healthcare spending also catalyze the market growth. Rising cases of organ failure leading to the requisite of organ transplantation further increase the demand in the organ preservation market. The increasing number of organ transplant procedures and the surging research being performed on organs have significantly increased the demand for organ preservation solutions. Increasing regulatory emphasis and various regulatory approvals for several relevant products in recent years have strengthened the market position of key players. Government support and initiatives taken by various non-profit organizations to facilitate organ transplants further enhance the demand in the market. However, the high cost associated with organ transplants and the complications associated with it are major challenges for market growth. The lacuna between the organs donated and organ transplants performed creates another barrier to market expansion.

Increasing Number of Organ Transplants

The increasing number of organ transplants is driving the demand for organ preservation products. Organ preservation solutions play a major role in safeguarding organs before transplantation, as isolated organs tend to deteriorate quickly. The reasons for increasing organ transplants include clinical advancements, high disposable income, and widespread awareness about organ donation and transplants. As per the data published by the Organ Procurement & Transplantation Network, in 2023, the number of deceased organ donors reached an unprecedented high of 16,000, marking 13 consecutive years of record-breaking donations. Moreover, the year witnessed an impressive increase in organ transplants, with over 46,000 life-saving procedures performed to overcome organ failures. Notably, liver transplants crossed the 10,000 mark for the first time, while lung transplants exceeded 3,000. Additionally, kidney and heart transplants also set new annual records, underscoring the remarkable progress in organ transplantation. Similarly, around 1589 kidney transplants, 761 liver, and 250 heart transplants were reported with India in the deceased category throughout the year 2022.

Advancements in Organ Preservation Methods

Organ preservation methods have progressively advanced throughout history, for the sake of optimizing organ transplantation outcomes. Subsequent innovations included refined formulations like the Collins, Euro-Collins, and University of Wisconsin (UW) solutions, which extended storage durations and enhanced organ viability. Presently, market players are focusing on developing products with revitalized strategies, particularly machine perfusion systems that offer a dynamic environment mimicking physiologic conditions. These systems provide opportunities for both organ repair and prolonged storage periods, reducing the chances of process failure. Ex vivo perfusion is one such extension of machine perfusion which aims to further enhance organ recovery through additional repair mechanisms and reprogramming processes.

In August 2023, TransMedics Group, Inc. announced the acquisition of assets and intellectual property from Bridge to Life Ltd., specifically the Ex-Vivo Organ Support System (EVOSS) and the LifeCradle Heart Preservation Transport System. LifeCradle is a cold perfusion technology used in heart transplantation, whereas EVOSS is a warm perfusion method used in lung and heart transplantation. As the company concentrates on expanding its product portfolio and applications in organ transplantation, TransMedics seeks to enhance these technologies.

Dominance of Static Cold Storage Technique

Static cold storage is preferred for organ preservation because it is a simple, cost-effective, and widely adopted method. It involves flushing the procured organ with preservation solution at a very low temperature and then immersing it in the same solution at the same temperature until transplantation. This technique significantly slows down cellular metabolism and maintains organ integrity, while minimizing the need for specialized equipment and reducing costs associated with alternative methods like machine perfusion. The cost-effectiveness of the static cold storage method is the major factor strengthening the lead of this technique. The hypothermic machine perfusion system segment is anticipated to grow at a relatively faster pace with the highest CAGR as market players are constantly working on it. For instance, in May 2023, Bridge to Life, Ltd. reported meeting promising standards from an interim analysis, prompting an early enrollment conclusion for its multicenter, randomized, controlled Bridge to HOPE Liver Clinical Trial (NCT05045794). This trial evaluates the clinical safety and effectiveness of the static cold storage (SCS) method, the conventional ex-vivo organ preservation technique, against a combination of SCS and hypothermic oxygenated perfusion (HOPE) using the VitaSmart Liver Machine Perfusion System. The trial is being conducted under a U.S. Food and Drug Administration (FDA)-approved investigational device exemption (IDE).

Kidney is the Most Commonly Preserved Organ

Kidneys are the most transplanted organ due to several factors. Kidney transplantation has a higher success rate, offering patients a better quality of life and increased longevity compared to remaining on dialysis. Kidney transplantation does not require removing the recipient's kidneys unless they are severely damaged or causing problems like high blood pressure or infection, making it less invasive than other types of organ transplantation. Additionally, compared to other vital organs like the heart, liver, and lungs, there are relatively more suitable kidney donors available, contributing to the frequency of kidney transplantation. Due to the high number of kidney transplants, the demand for preservation products for kidneys is anticipated to be higher. For instance, in 2023, kidney transplants in the United States reached an all-time high, with 27,329 surgeries performed as reported by the Organ Procurement and Transplantation Network (OPTN). Out of these transplantations, more than 6,900 involved living donors, with kidney transplants comprising over 90% of them. Additionally, the year saw an increase in the number of organ transplants, including kidney transplants, for Black and Hispanic individuals.

North America to be the Dominating Region

North America region is expected to dominate the market with a high-value share throughout the assessment period owing to the growing public commitment to organ donation and collaboration among donor hospitals, organ procurement organizations, and transplant hospitals, as well as advancements in organ preservation techniques and scientific breakthroughs. The United States being a medically advanced nation, has crossed the milestone of 1 million organ transplants in the year 2022. The technological advancements in the region to facilitate organ transplants have further boosted the market expansion in the region. Manufacturers also keep up their position by innovating new products.

For instance, in November 2023, Paragonix Technologies unveiled an extensive network of organ procurement, preservation, and transportation services. Seven specialized hubs have been strategically positioned across the United States to streamline coordination and support. These centers operate round the clock, featuring over 50 experienced professionals like surgeons and preservation experts, demonstrating Paragonix's commitment to revolutionizing organ transplantation.

Future Market Scenario (2024 - 2031F)

Machine perfusion is a new technique to keep organs healthy for transplantation. It works by using a special liquid that flows through the organ to keep it alive. This allows the organ to be stored for longer periods and repaired if it is damaged. Researchers are working to develop even better machine perfusion techniques and solutions to make organs even healthier before transplantation. This could lead to more successful transplants and save more lives. For instance, in March 2023, The FDA granted XT-ViVo and TimeSeal a special designation called "Breakthrough Device Designation" because they can preserve and store kidneys for up to 120 hours. These products could be used to preserve other organs and tissues. Current methods preserve organs for only 4-16 hours, leading to waste, discarding, and countless organs not being recovered. In February 2023, LivaNova PLC unveiled the Essenz Perfusion System in Europe for cardiopulmonary bypass surgical interventions. This cutting-edge device combines a sophisticated heart-lung machine with a revolutionary patient monitor, delivering real-time critical care insights during CPB procedures.

Key Players Landscape and Outlook

XVIVO Perfusion AB, TransMedics, Inc., Preservation Solutions, Inc., Paragonix Technologies, Inc., Dr. Franz Kohler Chemie GmbH, and Waters Medical Systems LLC are some of the renowned players in the organ preservation market. These companies focus on developing and supplying organ preservation solutions, such as University of Wisconsin (UW) Solution, Custodial HTK, Perfadex, and others, while employing different preservation techniques like static cold storage, hypothermic machine perfusion, and normothermic machine perfusion. Regulatory advancements and collaboration lead the way for market expansion. The market is mainly dominated by privately held companies.

In February 2024, Bridge to Life Ltd announced that it had received ISO 13485:2016 certification. This achievement highlights the company's dedication to quality and safety in its products, including Belzer UW, EasiSlush, and VitaSmart1 Machine Perfusion System (Europe). The certification is a strategic move in preparation for the launch of the VitaSmart1 Machine Perfusion System in the US, pending FDA approval. Bridge to Life consistently strives to meet and surpass industry standards.

In February 2024, Atrium Health's Transplant Division, Carolinas Medical Center, joined forces with LifeShare Carolinas and BMI OrganBank to introduce pioneering Organ Banking technology. This advanced system will expand organ preservation and reconditioning possibilities. Atrium Health is among the top five Integrated Delivery Networks in the United States.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Organ Preservation Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2.By Solution
    • 4.2.1.University of Wisconsin Solution (UW Solution)
    • 4.2.2.Custodial HTK
    • 4.2.3.Perfadex
    • 4.2.4.Other Solutions
  • 4.3.By Technique
    • 4.3.1.Static Cold Storage
    • 4.3.2.Hypothermia Machine Perfusion
    • 4.3.3.Normothermic Machine Perfusion
  • 4.4.By Organ Type
    • 4.4.1.Kidney
    • 4.4.2.Liver
    • 4.4.3.Lung
    • 4.4.4.Heart
    • 4.4.5.Pancreas
    • 4.4.6.Others
  • 4.5.By End-user
    • 4.5.1.Organ Transplant Centers
    • 4.5.2.Hospitals
    • 4.5.3.Specialty Clinics
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.Europe
    • 4.6.3.Asia-Pacific
    • 4.6.4.South America
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Organ Preservation Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Solution
      • 5.1.2.1.University of Wisconsin Solution (UW Solution)
      • 5.1.2.2.Custodial HTK
      • 5.1.2.3.Perfadex
      • 5.1.2.4.Other Solutions
    • 5.1.3.By Technique
      • 5.1.3.1.Static Cold Storage
      • 5.1.3.2.Hypothermia Machine Perfusion
      • 5.1.3.3.Normothermic Machine Perfusion
    • 5.1.4.By Organ Type
      • 5.1.4.1.Kidney
      • 5.1.4.2.Liver
      • 5.1.4.3.Lung
      • 5.1.4.4.Heart
      • 5.1.4.5.Pancreas
      • 5.1.4.6.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Organ Transplant Centers
      • 5.1.5.2.Hospitals
      • 5.1.5.3.Specialty Clinics
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Solution
      • 5.1.6.2.1.University of Wisconsin Solution (UW Solution)
      • 5.1.6.2.2.Custodial HTK
      • 5.1.6.2.3.Perfadex
      • 5.1.6.2.4.Other Solutions
      • 5.1.6.3.By Technique
      • 5.1.6.3.1.Static Cold Storage
      • 5.1.6.3.2.Hypothermia Machine Perfusion
      • 5.1.6.3.3.Normothermic Machine Perfusion
      • 5.1.6.4.By Organ Type
      • 5.1.6.4.1.Kidney
      • 5.1.6.4.2.Liver
      • 5.1.6.4.3.Lung
      • 5.1.6.4.4.Heart
      • 5.1.6.4.5.Pancreas
      • 5.1.6.4.6.Others
      • 5.1.6.5.By End-user
      • 5.1.6.5.1.Organ Transplant Centers
      • 5.1.6.5.2.Hospitals
      • 5.1.6.5.3.Specialty Clinics
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Solution
  • 6.2.By Technique
  • 6.3.By Organ Type
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.XVIVO Perfusion AB
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.TransMedics, Inc.
  • 13.3.Preservation Solutions, Inc.
  • 13.4.Paragonix Technologies, Inc.
  • 13.5.Dr. Franz Kohler Chemie GmbH
  • 13.6.Waters Medical Systems LLC
  • 13.7.OrganOx Limited
  • 13.8.21st Century Medicine Inc.
  • 13.9.Bridge to Life Ltd.
  • 13.10.Essential Pharmaceuticals LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 2.Global Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 4.Global Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 5.Global Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 6.Global Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Organ Preservation Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 9.North America Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 11.North America Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 12.North America Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 13.North America Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 16.United States Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 18.United States Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 19.United States Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 20.United States Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 22.Canada Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 24.Canada Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 25.Canada Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 26.Canada Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 28.Mexico Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 30.Mexico Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 31.Mexico Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 32.Mexico Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 34.Europe Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 36.Europe Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 37.Europe Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 38.Europe Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 41.Germany Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 43.Germany Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 44.Germany Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 45.Germany Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 47.France Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 49.France Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 50.France Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 51.France Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 53.Italy Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 55.Italy Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 56.Italy Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 57.Italy Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 59.United Kingdom Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 61.United Kingdom Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 62.United Kingdom Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 63.United Kingdom Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 65.Russia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 67.Russia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 68.Russia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 69.Russia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 71.Netherlands Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 73.Netherlands Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 74.Netherlands Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 75.Netherlands Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 77.Spain Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 79.Spain Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 80.Spain Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 81.Spain Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 83.Turkey Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 85.Turkey Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 86.Turkey Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 87.Turkey Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 89.Poland Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 91.Poland Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 92.Poland Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 93.Poland Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 95.South America Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 97.South America Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 98.South America Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 99.South America Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 102.Brazil Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 104.Brazil Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 105.Brazil Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 106.Brazil Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 108.Argentina Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 110.Argentina Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 111.Argentina Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 112.Argentina Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 114.Asia-Pacific Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 116.Asia-Pacific Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 117.Asia-Pacific Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 118.Asia-Pacific Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 120.India Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 121.India Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 123.India Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 124.India Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 125.India Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 127.China Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 129.China Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 130.China Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 131.China Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 133.Japan Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 135.Japan Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 136.Japan Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 137.Japan Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 139.Australia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 141.Australia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 142.Australia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 143.Australia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 145.Vietnam Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 147.Vietnam Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 148.Vietnam Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 149.Vietnam Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 151.South Korea Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 153.South Korea Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 154.South Korea Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 155.South Korea Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 157.Indonesia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 159.Indonesia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 160.Indonesia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 161.Indonesia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 163.Philippines Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 165.Philippines Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 166.Philippines Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 167.Philippines Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 169.Middle East & Africa Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 171.Middle East & Africa Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 172.Middle East & Africa Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 173.Middle East & Africa Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 176.Saudi Arabia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 178.Saudi Arabia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 179.Saudi Arabia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 180.Saudi Arabia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 182.UAE Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 184.UAE Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 185.UAE Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 186.UAE Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 188.South Africa Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 190.South Africa Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 191.South Africa Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 192.South Africa Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Solution Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194.By Technique Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195.By Organ Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023